Rx News
Cranberry-Active Proven to Treat and Prevent Vaginal Infections
April 23, 2013
Instead of traditional treatment with antibiotics or chemical substances, vaginal infections can be treated and prevented by using Cranberry-Active tablets, developed by Dutch company Medical Brands. The company has obtained a European Class IIa Medical Device Status for its patented Cranberry-Active tablet, making it the first and only cranberry-based product in Europe which has a proven medical claim to treat and prevent vaginal infections.
After the successful introduction of Cranberry-Active capsules for the treatment of bladder- and urinary tract infections in 2012, Medical Brands and American company NATUREX-DBS together have introduced their latest development for treatments of vaginal infections.
"Vaginal Infections are a serious health problem, affecting one of every three women during their lifetime," says Maikel Hendriks, president of Medical Brands. " After the first treatment, another 30 percent will suffer from re-occurrence within three months and 80 percent within nine months."
While the claims of other cranberry-based food supplements and pro-biotic vaginal products have been rejected by the European Food and Safety Authority (EFSA), Medical Brands produced studies which clinically showed that the Cranberry-Active treats and prevents vaginal infections. The product can be freely sold as a self-care medical device on the OTC market in all European countries.
Maikel Hendriks: "Our Cranberry-Active marketing authorization is the culmination of years of planning, development and clinical investigation. We answer to a growing global push towards safe and natural solutions as the resistance to antibiotics continues to rise."
His company is specialised in developing self-care medical devices without pharmacologic effects. It provides consumers with solutions for everyday diseases without the side effects that most drugs have.
In the Netherlands and Scandinavia the tablet is sold as the Vaginal Infection Tablet by 'i say'. In other countries Medical Brands is still searching for partners to distribute the products.
News Topics
Top News Articles
- New Parkinson's Disease Drug Approved
May 4, 2017 - Hypertension Guidelines Consensus Statement
April 1, 2017 - Novel Abuse-Deterrent Morphine Approved
March 1, 2017 - New Heart Failure Guidelines
February 1, 2017 - New Eczema Drug Approved
January 1, 2017